739 related articles for article (PubMed ID: 7726699)
21. Treatment of nonvalvular atrial fibrillation.
Stettin GD
West J Med; 1995 Apr; 162(4):331-9. PubMed ID: 7747499
[TBL] [Abstract][Full Text] [Related]
22. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M
G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
[TBL] [Abstract][Full Text] [Related]
23. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
24. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
25. Atrial fibrillation: preventing thromboembolism and choosing nondrug therapies.
Chandramouli BV; Kotler MN
Geriatrics; 1998 Jul; 53(7):53-60. PubMed ID: 9672497
[TBL] [Abstract][Full Text] [Related]
26. Prevention of thromboembolic events in atrial fibrillation.
Koefoed BG; Gulløv AL; Petersen P
Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
[TBL] [Abstract][Full Text] [Related]
27. Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide.
Zarembski DG; Nolan PE; Slack MK; Caruso AC
Arch Intern Med; 1995 Sep; 155(17):1885-91. PubMed ID: 7677555
[TBL] [Abstract][Full Text] [Related]
28. Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.
King DE; Dickerson LM; Sack JL
Am Fam Physician; 2002 Jul; 66(2):261-4. PubMed ID: 12152961
[TBL] [Abstract][Full Text] [Related]
29. [Frontiers in prevention of thromboembolism in nonvalvular atrial fibrillation].
Fukunami M
J Cardiol; 1999 Mar; 33 Suppl 1():65-70. PubMed ID: 10342139
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
Flaker G; Lopes RD; Al-Khatib SM; Hermosillo AG; Hohnloser SH; Tinga B; Zhu J; Mohan P; Garcia D; Bartunek J; Vinereanu D; Husted S; Harjola VP; Rosenqvist M; Alexander JH; Granger CB;
J Am Coll Cardiol; 2014 Mar; 63(11):1082-7. PubMed ID: 24211508
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of amiodarone and quinidine in the conversion to sinusal rhythm of atrial fibrillation of recent onset].
Negrini M; Gibelli G; De Ponti C
G Ital Cardiol; 1990 Mar; 20(3):207-14. PubMed ID: 2344898
[TBL] [Abstract][Full Text] [Related]
32. [Long-term fate of 103 patients with auricular fibrillation lasting for over 15 days treated with cardioversion and preventive therapy].
Roussane A; Blanc P; Virot P; Doumeix JJ; Chabanier A; Bensaid J; Blanc G
Ann Cardiol Angeiol (Paris); 1984 Nov; 33(7):449-52. PubMed ID: 6508194
[TBL] [Abstract][Full Text] [Related]
33. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
Garwood CL; Hwang JM; Moser LR
Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
[TBL] [Abstract][Full Text] [Related]
34. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
35. Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: a single-center pilot study.
Pianelli M; Scaglione M; Anselmino M; Caponi D; Garcia P; Cesarani F; Toso E; Raimondo C; Halimi F; Leclercq JF; Gaita F
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):785-9. PubMed ID: 21941200
[TBL] [Abstract][Full Text] [Related]
36. [Atrial fibrillation--thromboembolism and prevention].
Petersen P; Boysen G; Godtfredsen J
Ugeskr Laeger; 1991 Jul; 153(30):2105-7. PubMed ID: 1866811
[TBL] [Abstract][Full Text] [Related]
37. [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
Klein HH
Dtsch Med Wochenschr; 2013 Jun; 138(24):1309-11. PubMed ID: 23737116
[TBL] [Abstract][Full Text] [Related]
38. Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?
Michael Gray R; Nagendran M; Maruthappu M
Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):642-8. PubMed ID: 21885540
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation.
Catherwood E; Fitzpatrick WD; Greenberg ML; Holzberger PT; Malenka DJ; Gerling BR; Birkmeyer JD
Ann Intern Med; 1999 Apr; 130(8):625-36. PubMed ID: 10215558
[TBL] [Abstract][Full Text] [Related]
40. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.
Manning WJ; Silverman DI; Keighley CS; Oettgen P; Douglas PS
J Am Coll Cardiol; 1995 May; 25(6):1354-61. PubMed ID: 7722133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
